CHRS Stock Summary

• Coherus BioSciences Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 88.65% of US listed stocks.
• CHRS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 0.51% of US stocks.
• As for revenue growth, note that CHRS's revenue has grown 525.95% over the past 12 months; that beats the revenue growth of 98.68% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to Coherus BioSciences Inc, a group of peers worth examining would be LXRX, SMSI, CPRX, MCHX, and ACMR.
• Visit CHRS's SEC page to see the company's official filings. To visit the company's web site, go to www.coherus.com.